199 related articles for article (PubMed ID: 31359329)
1. The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder.
Suehs BT; Caplan EO; Hayden J; Ng DB; Gaddy RR
Drugs Aging; 2019 Oct; 36(10):957-967. PubMed ID: 31359329
[TBL] [Abstract][Full Text] [Related]
2. Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study.
Szabo SM; Gooch K; Schermer C; Walker D; Lozano-Ortega G; Rogula B; Deighton A; Vonesh E; Campbell N
BMJ Open; 2019 May; 9(5):e026391. PubMed ID: 31061036
[TBL] [Abstract][Full Text] [Related]
3. Effects of anticholinergic and sedative medication use on fractures: A self-controlled design study.
Shmuel S; Pate V; Pepin MJ; Bailey JC; Golightly YM; Hanson LC; Stürmer T; Naumann RB; Gnjidic D; Lund JL
J Am Geriatr Soc; 2021 Nov; 69(11):3212-3224. PubMed ID: 34291817
[TBL] [Abstract][Full Text] [Related]
4. Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics.
Yehoshua A; Chancellor M; Vasavada S; Malone DC; Armstrong EP; Joshi M; Campbell K; Pulicharam R
J Manag Care Spec Pharm; 2016 Apr; 22(4):406-13. PubMed ID: 27023694
[TBL] [Abstract][Full Text] [Related]
5. The risk of delirium and falls or fractures with the use of overactive bladder anticholinergic medications.
Welk B; Etaby K; McArthur E; Chou Q
Neurourol Urodyn; 2022 Jan; 41(1):348-356. PubMed ID: 34719044
[TBL] [Abstract][Full Text] [Related]
6. Impact of Coexisting Overactive Bladder in Medicare Patients With Dementia on Clinical and Economic Outcomes.
Caplan EO; Abbass IM; Suehs BT; Ng DB; Gooch K; van Amerongen D
Am J Alzheimers Dis Other Demen; 2019; 34(7-8):492-499. PubMed ID: 30966757
[TBL] [Abstract][Full Text] [Related]
7. A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA.
Campbell NL; Hines L; Epstein AJ; Walker D; Lockefeer A; Shiozawa A
Drugs Aging; 2021 Dec; 38(12):1075-1085. PubMed ID: 34746992
[TBL] [Abstract][Full Text] [Related]
8. Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder.
Jaggi A; Nazir J; Fatoye F; Quelen C; Tu X; Ali M; Siddiqui E; Covernton PJO; Landeira M; Choudhury N
Drugs Aging; 2021 Oct; 38(10):911-920. PubMed ID: 34386936
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression.
Chatterjee S; Bali V; Carnahan RM; Chen H; Johnson ML; Aparasu RR
J Am Geriatr Soc; 2016 Jul; 64(7):1492-7. PubMed ID: 27294403
[TBL] [Abstract][Full Text] [Related]
10. Overactive bladder in an integrated delivery system: a longitudinal cohort study.
Linder JA; Weissman JS; Reyes Nieva H; Lipsitz S; Haring RS; DeAngelis J; Kristy RM; Loughlin KR
BMC Health Serv Res; 2020 May; 20(1):447. PubMed ID: 32434511
[TBL] [Abstract][Full Text] [Related]
11. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
12. Use of Medications with Anticholinergic Properties and the Long-Term Risk of Hospitalization for Falls and Fractures in the EPIC-Norfolk Longitudinal Cohort Study.
Tan MP; Tan GJ; Mat S; Luben RN; Wareham NJ; Khaw KT; Myint PK
Drugs Aging; 2020 Feb; 37(2):105-114. PubMed ID: 31808140
[TBL] [Abstract][Full Text] [Related]
13. Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA.
Chen JV; Gahn JC; Nesheim J; Mudd PN
Pharmacoeconomics; 2022 Oct; 40(10):979-988. PubMed ID: 35881325
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder.
Chatterjee S; Walker D; Kimura T; Aparasu RR
Drugs Aging; 2021 Apr; 38(4):311-326. PubMed ID: 33682017
[TBL] [Abstract][Full Text] [Related]
15. Dementia Associated with Anticholinergic Drugs Used for Overactive Bladder: A Nested Case-Control Study Using the French National Medical-Administrative Database.
Malcher MF; Droupy S; Berr C; Ziad A; Huguet H; Faillie JL; Serrand C; Mura T
J Urol; 2022 Oct; 208(4):863-871. PubMed ID: 35686842
[TBL] [Abstract][Full Text] [Related]
16. Impact of anticholinergic burden on emergency department visits among older adults in Korea: A national population cohort study.
Hwang S; Jun K; Ah YM; Han E; Chung JE; Lee JY
Arch Gerontol Geriatr; 2019; 85():103912. PubMed ID: 31386937
[TBL] [Abstract][Full Text] [Related]
17. Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study.
Just KS; Schultze KA; Dormann H; Seufferlein T; Gräff I; Scholl C; Schwab M; Stingl JC
Eur J Clin Pharmacol; 2023 Sep; 79(9):1185-1193. PubMed ID: 37382655
[TBL] [Abstract][Full Text] [Related]
18. Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder.
Chancellor MB; Migliaccio-Walle K; Bramley TJ; Chaudhari SL; Corbell C; Globe D
Clin Ther; 2013 Nov; 35(11):1744-51. PubMed ID: 24091072
[TBL] [Abstract][Full Text] [Related]
19. No Increased Risk of Fracture in Patients Receiving Antimuscarinics for Overactive Bladder Syndrome: A Retrospective Cohort Study.
Kao LT; Huang CY; Lin HC; Chu CM
J Clin Pharmacol; 2018 Jun; 58(6):727-732. PubMed ID: 29315618
[TBL] [Abstract][Full Text] [Related]
20. The Association Between Overactive Bladder and Falls and Fractures: A Systematic Review.
Szabo SM; Gooch KL; Walker DR; Johnston KM; Wagg AS
Adv Ther; 2018 Nov; 35(11):1831-1841. PubMed ID: 30255417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
